Literature DB >> 7199825

In vitro stimulation of cell growth by hepatic stimulator substance.

D R LaBrecque.   

Abstract

An extract of normal weanling or adult regenerating rat liver called hepatic stimulator substance (HSS) stimulates incorporation of tritiated thymidine ([3H]dThd) into liver DNA. In vivo, it is organ specific, species nonspecific, displays diurnal rhythm, and has a molecular weight of approximately 10,000-20,000. It has now been further characterized in vitro. HSS retained organ specificity, stimulating normal adult hepatocytes in primary culture, the HTC, PLC, and MH1C1 hepatoma cell lines, and the PRC rat liver cell line. It did not stimulate human or mouse lymphocytes, 3T3 mouse fibroblasts, Y1BS1 mouse adrenal cells, Chinese hamster ovary cells, rat hypernephroma cells, C6 rat glial cells, or L1210 mouse leukemic cells. More detailed studies of the response of HTC cells to HSS revealed a dose-dependent increase in [3H]dThd incorporation (up to 30-fold) with a response to as little as 140-ng purified extract/ml culture medium. Autoradiography confirmed that the thymidine was taken up by nuclear DNA. This represented a true stimulation of growth as shown by an almost twofold increase in cell number after 6 days of exposure to low doses of HSS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7199825     DOI: 10.1152/ajpgi.1982.242.3.G289

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Hepatic stimulator substance. Discovery, characteristics and mechanism of action.

Authors:  D R LaBrecque
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

2.  Effect of heat and pH denaturation on the structure and conformation of recombinant human hepatic stimulator substance.

Authors:  Zhi-cheng Yang; Lin Yang; Ying-xia Zhang; He-fen Yu; Wei An
Journal:  Protein J       Date:  2007-08       Impact factor: 2.371

3.  Response of cultured hepatocytes to a hepatomitogen after initiation by conditioned medium or other factors.

Authors:  P Ove; A Francavilla; M L Coetzee; L Makowka; T E Starzl
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

4.  Direct analysis of growth factor requirements for isolated human fetal hepatocytes.

Authors:  H Hoshi; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol       Date:  1987-10

5.  Epidermal growth factor and proliferation in rat hepatocytes in primary culture isolated at different times after partial hepatectomy.

Authors:  A Francavilla; P Ove; L Polimeno; C Sciascia; M L Coetzee; T E Starzl
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

6.  The characterization and partial purification of hepatocyte proliferation factor.

Authors:  L C Schwarz; L Makowka; J A Falk; R Falk
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

7.  Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.

Authors:  E Gohda; H Tsubouchi; H Nakayama; S Hirono; O Sakiyama; K Takahashi; H Miyazaki; S Hashimoto; Y Daikuhara
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

8.  Compensatory hyperplasia in the rat liver as a result of cytoplasmic atrophy.

Authors:  M R Alison; C J Ryan; C A Lee; K McDermott
Journal:  Br J Exp Pathol       Date:  1986-12

9.  Effect of acute ethanol exposure on hepatic stimulator substance (HSS) levels during liver regeneration: protective function of HSS.

Authors:  George D Liatsos; Michael G Mykoniatis; Alexandra Margeli; Aristotelis A Liakos; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.